With a market cap of $24.6 billion, Biogen Inc. (BIIB) is a global biotechnology leader specializing in therapies for neurological and neurodegenerative diseases. Its portfolio includes multiple …
Biogen Stock: Is Wall Street Bullish or Bearish?
view original post